Adrenocortical carcinoma is a rare heterogeneous neoplasm with an incompletely
understood pathogenesis and a poor prognosis. Previous studies have identified …

Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing
attention during the last decade. Here we provide an update on advances in the field since …

Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy, and most of the
diagnostic and therapeutic strategies are not fully established according to criteria of …

Context: Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with
incompletely understood pathogenesis and poor prognosis. Patients present with hormone …

CONTEXT: Adrenocortical carcinoma (ACC) is a rare and typically aggressive malignancy.
Available recommendations are based primarily on retrospective series or expert opinions …

Adrenocortical carcinoma is a rare endocrine malignant disease with a generally
unfavorable but heterogeneous prognosis. Although even in advanced stages a subset of …

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable
prognosis. Here we summarize the knowledge about diagnosis, epidemiology …

Adrenocortical cancer (ACC) is a rare and often aggressive malignancy that requires
multidisciplinary expertise for optimal management. It can present with symptoms of rapidly …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. ACC is capable
of secreting excess adrenocortical hormones, which can compound morbidity and …

Abstract Purpose of Review Adrenocortical carcinoma (ACC) is a rare endocrine malignancy
typically with poor prognosis. This review aims to summarize the current knowledge …